Evidence map›Paper›PMID 31766734›Full record

ArticleInternational journal of molecular sciences2019

microRNAs Regulating Human and Mouse Naïve Pluripotency.

Yuliang Wang, Abdiasis M Hussein, Logeshwaran Somasundaram, Rithika Sankar, Damien Detraux, Julie Mathieu, Hannele Ruohola-Baker

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. AntiZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuliang WangPaul G. Allen School of Computer Science & Engineering, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-5588-4531
Abdiasis M HusseinInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Logeshwaran SomasundaramInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.ORCID 0000-0001-8060-8988
Rithika SankarInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Damien DetrauxInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.ORCID 0000-0002-9704-2076
Julie MathieuInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Hannele Ruohola-BakerInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
University of Washington · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
National Institute of Health 1P01GM081619NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

microRNAs are ~22bp nucleotide non-coding RNAs that play important roles in the post-transcriptional regulation of gene expression. Many studies have established that microRNAs are important for cell fate choices, including the naïve to primed pluripotency state transitions, and their intermediate state, the developmentally suspended diapause state in early development. However, the full extent of microRNAs associated with these stage transitions in human and mouse remain under-explored. By meta-analysis of microRNA-seq, RNA-seq, and metabolomics datasets from human and mouse, we found a set of microRNAs, and importantly, their experimentally validated target genes that show consistent changes in naïve to primed transitions (microRNA up, target genes down, or vice versa). The targets of these microRNAs regulate developmental pathways (e.g., the Hedgehog-pathway), primary cilium, and remodeling of metabolic processes (oxidative phosphorylation, fatty acid metabolism, and amino acid transport) during the transition. Importantly, we identified 115 microRNAs that significantly change in the same direction in naïve to primed transitions in both human and mouse, many of which are novel candidate regulators of pluripotency. Furthermore, we identified 38 microRNAs and 274 target genes that may be involved in diapause, where embryonic development is temporarily suspended prior to implantation to uterus. The upregulated target genes suggest that microRNAs activate stress response in the diapause stage. In conclusion, we provide a comprehensive resource of microRNAs and their target genes involved in naïve to primed transition and in the paused intermediate, the embryonic diapause stage.

Indexed as

Databases, GeneticMicroRNAsAnimalsHuman Embryonic Stem CellsHumansInduced Pluripotent Stem CellsMiceMouse Embryonic Stem CellsMicroRNAsembryonic diapausemicroRNAnaïve and primed pluripotent stem cellsshh

Identifiers

PMID31766734
PMCPMC6929104
OpenAlexW2990999068

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.